Business Description
This fund tracks a specific index made up of pharmaceutical and biotechnology companies whose shares are listed on major stock exchanges in developed markets. It follows a straightforward, rule-based system to select these companies and aims to hold at least 80% of its assets in the same securities that make up the index. The fund does not spread its investments broadly across many different sectors or asset types.
